DSDavid L. Shelton

David L. Shelton

*This is an algorithmically generated author record based on publicly available information.

David L. Shelton has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Arnon Rosenthal

    Rinat Neuroscience Corp., 3155 Porter Drive, Palo Alto, CA 94304, USA

    1 shared publication
  • Jaume Pons

    Rinat Neuroscience Corp., 3155 Porter Drive, Palo Alto, CA 94304, USA

    1 shared publication
  • Jörg Zeller

    Rinat Neuroscience Corp., 3155 Porter Drive, Palo Alto, CA 94304, USA

    1 shared publication
  • Wei-Hsien Ho

    Rinat Neuroscience Corp., 3155 Porter Drive, Palo Alto, CA 94304, USA

    1 shared publication

Latest Publications

  • Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis

    by David L. Shelton, Jörg Zeller, Wei-Hsien Ho, Jaume Pons, Arnon Rosenthal

    Pain and cachexia are two of the most debilitating aspects of rheumatoid arthritis. Despite that, the mechanisms by which they are mediated are not well understood. We provide evidence that nerve growth factor (NGF), a secreted regulatory protein that controls neuronal survival during development, is a key mediator of pain and weight loss in auto-immune arthritis. Function blocking antibodies to NGF completely reverse established pain in rats with fully developed arthritis despite continuing joint destruction and inflammation. Likewise, these antibodies reverse weight loss while not having any effect on levels of the pro-cachectic agent tumor necrosis factor (TNF). Taken together, these findings argue that pathological joint pain and joint destruction are mechanistically independent processes and that NGF regulates an alternative cachexia pathway that is independent or downstream of TNF.